Document is current
Any future updates will be listed below
-
Authors
Wang, Fen
Zhao, Zhengyang
Li, Zhuanghua
Chen, Xiaolei
Lu, Weihong
Yao, Shuying
Xi, Jiameng
Sun, Yanshuo
Luo, Huirou
Feng, Qingyuan
Lv, Shuguang
Xu, Piao
Shen, Lingjia
Zhang, Wenqing
Zhan, Yan-yan https://orcid.org/0000-0003-3962-0349
Xie, Liangxi https://orcid.org/0000-0003-1834-2319
Hu, Tianhui https://orcid.org/0000-0003-3998-5145
Hong, Xiaoting https://orcid.org/0000-0002-0787-4136
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Fujian Province (2024R1037)
Natural Science Foundation of Fujian Province (2024D033)
Natural Science Foundation of Fujian Province (2025R1001002)
National Natural Science Foundation of China (32270833)
National Natural Science Foundation of China (82472651)
Shenzhen Science and Technology Innovation Commission (JCYJ20210324121802008)
Shenzhen Science and Technology Innovation Commission (JCYJ20220530143406015)
- License Information
-
More Information
Article History
Received: 30 October 2025
Revised: 17 April 2026
Accepted: 14 May 2026
First Online: 30 May 2026
Competing interests
: The authors declare no competing interests.
: All methods in this study were performed in accordance with the relevant guidelines and regulations. The use of human ovarian cancer tissue specimens was approved by the Medical Ethics Committee of Zhongshan Hospital, Xiamen University (ethical approval number: 20190003), and the study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to inclusion in the study. The study does not include any identifiable images of human participants. All animal experiments were approved by the Animal Care and Use Committee of Xiamen University (animal ethics approval number: XMULAC20250121) and were performed in accordance with the national and institutional guidelines and regulations for the care and use of laboratory animals, as well as the ARRIVE guidelines.
